| 公告编号：2025-044 | | --- | | 证券简称：新疆交建 | | 证券代码：002941 | 债券代码：128132 债券简称：交建转债 新疆交通建设集团股份有限公司 2025 年第一次临时股东会决议公告 载、误导性陈述或重大遗漏。 特别提示： 1.本次股东会未出现否决提案的情形。 2.本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 1.会议召开时间： （1）现场会议时间:2025年7月30日（星期三）北京时间15：00 （2）网络投票时间:2025年7月30日，其中，通过深圳证券交易所交易系统 进行网络投票的具体时间为:2025年7月30日上午9:15分至9:25，上午9:30分至 11:30，下午13:00至15:00；通过深圳证券交易所互联网投票的具体时间为:2025 年7月30日上午9:15分至下午15:00期间的任意时间。 2.会议召开地点：新疆乌鲁木齐市高新技术产业开发区（新市区）乌昌路辅 道840号新疆交通建设集团股份有限公司科研楼二楼会议室。 3.会议召开方式：本 ...

国浩律师(乌鲁木齐)事务所 股东大会法律意见书 国浩律师(乌鲁木齐)事务所 关于新疆交通建设集团股份有限公司 二0二五年第一次临时股东会 法律意见书 律師事務所 GRANDALL LAW FIRM 北京 · 上海 · 深圳 · 广州 · 昆明 · 天津 · 成都 · 宁波 · 福州 · 西安 · 南京 · 南宁 · 济南 · 重庆 · 苏州 · 长沙 · 太原 · 武汉 · 贵阳 · 乌鲁木齐 · 香港 · 珪谷 新疆乌鲁木齐经济技术开发区云台山街 499 号盛达广场 15 层 郵編: 83000 電話: (+86)(991) 3070688 傳真: (+86)(991)3070288 網址:http://www.grandall.com.cn l 国浩律师(乌鲁木齐)事务所 股东大会法律意见书 国浩律师(乌鲁木齐)事务所 关于新疆交通建设集团股份有限公司 二0二五年第一次临时股东会法律意见书 致:新疆交通建设集团股份有限公司 国浩律师(乌鲁木齐)事务所(下称本所)接受新疆交通建设集团股份有限 公司 (下称公司)的委托,委派本所赵旭东律师、郑馨律师出席公司 2025年第 一次临时股东会,根据《中华人民共和国公 ...

证券日报网讯新疆交建（002941）7月29日在互动平台回答投资者提问时表示，公司为深入推进企业战 略性重组和专业化整合，加快推动现代化产业体系建设，已于2024年1月将水利事业部、基础设施公司 进行专业化整合，整合后基础设施公司的水利业务业绩占公司主营业务比例较小，公司未来将持续加大 市场开拓力度，争取更多的市场份额。 ...

Overall Situation - Xinjiang Transportation Construction Group Co., Ltd. reported a total of 20 newly signed construction projects with a total contract value of approximately 1.43 billion yuan [1] - The company has 10 new projects that are signed but not yet started, valued at approximately 764.34 million yuan [1] - There are 356 ongoing projects with a total value of approximately 27.03 billion yuan [1] Major Project Performance - The Urumqi East Elevated Road project, signed in 2017, has a contract value of 4.043 billion yuan and is currently 100% completed [1] - The Changji State Key Road Special Project (S228) has a contract value of 2.145 billion yuan and is in progress, with 9.92% completion compared to the last measurement period [1] - The company confirms that there are no significant changes in the performance capabilities of the counterparties involved in these major projects [1]

Group 1 - Leshan Electric achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 1.94%, and a net profit of 7.9031 million yuan, a year-on-year decrease of 14.55% [1] - Zhimingda reported operating revenue of 295 million yuan, a year-on-year increase of 84.83%, and a net profit of 38.3 million yuan, a year-on-year increase of 2147.93% [2] - Dahu Co. reported operating revenue of 426 million yuan, a year-on-year decrease of 14.40%, and a net loss of 2.5716 million yuan, an improvement from a loss of 13.7824 million yuan in the same period last year [3] - Yubang Electric expects a net profit of 21.2 million to 25 million yuan, a year-on-year decrease of 35.47% to 45.28% [4] - Zhejiang Securities achieved operating revenue of 6.512 billion yuan, a year-on-year decrease of 18.60%, and a net profit of 1.149 billion yuan, a year-on-year increase of 46.54% [5] - Huashu Media reported operating revenue of 4.435 billion yuan, a year-on-year increase of 2.07%, and a net profit of 254 million yuan, a year-on-year increase of 4.63% [7] Group 2 - Sinopec reported oil and gas equivalent production of 262.81 million barrels, a year-on-year increase of 2%, and crude oil processing volume of 119.97 million tons, a year-on-year decrease of 5.3% [8] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS8179, aimed at reducing brain edema after stroke [8] - Hengrui Medicine's subsidiary also received approval for clinical trials of HRS-1893, intended for treating heart failure with preserved ejection fraction [8] - Wanfu Co. announced a plan to reduce its stake by up to 2% through block trading [10] - Biological Co. received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inaccuracies in financial reporting [11] - Zhujiang Co. reported a signed construction area of 47.1432 million square meters across 396 projects [13] Group 3 - Watson Bio received a patent for a peptide delivery system for RNA drugs [15] - Sanwei Chemical signed 31 new contracts worth 335 million yuan in the second quarter [17] - Shenzhou Cell's SCT640C injection received approval for clinical trials for rheumatoid arthritis [18] - Xinjiang Jiaojian reported new contracts worth 1.434 billion yuan in the second quarter [19] - Lais Information plans to use 550 million yuan of idle funds for cash management [21] - Zhongqi New Materials signed a mining rights transfer contract, increasing production capacity [22] Group 4 - Hengtong Optic-Electric won multiple marine energy projects worth 1.509 billion yuan [24] - China State Construction signed new contracts totaling 2.501 trillion yuan in the first half of the year [26] - David Medical's ventilator product registration application has been accepted [28] - Tianhai Defense's subsidiary signed a construction contract worth 16.224 million yuan [29] - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [31] - Baida Group announced a plan to reduce its stake by up to 3% [32] Group 5 - Jinli Permanent Magnet plans to issue $117.5 million in convertible bonds [34] - Haizheng Pharmaceutical's fumarate bedaquiline raw material drug application has been approved [36] - Huatai passed the advanced intelligent factory re-evaluation in Anhui Province [37] - Everbright Bank's shareholder increased its stake from 7.08% to 8% [40] - Supor reported total operating revenue of 11.478 billion yuan, a year-on-year increase of 4.68%, and a net profit of 940 million yuan, a year-on-year decrease of 0.07% [41] - Qianjin Pharmaceutical's subsidiaries received registration certificates for two drugs [42]

| 证券代码：002941 | 证券简称：新疆交建 | 公告编号：2025-043 | | --- | --- | --- | | 债券代码：128132 | 债券简称：交建转债 | | 新疆交通建设集团股份有限公司 2025 年第二季度建筑业经营情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 项目 类型 新中标且签约项目 新中标未签约项目 截至报告期末累计已签 约未完工项目 数量（个） 金额（万元） 数 量 （个） 金额（万元） 数 量 （个） 金额（万元） 施工 项目 20 143,392.47 10 76,433.98 356 2,702，667.65 合计 20 143,392.47 10 76,433.98 356 2,702，667.65 一、总体情况 | 昌吉州重 | | | | | | | | | 正在履行，合同已签， | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 要省道特 | | | | | | | | | 已完成项目施工的 | | 许经营项 | ...

Group 1 - The company Xinjiang Jiaojian (002941) announced that in the second quarter, it secured 20 new construction projects with a total value of 1.434 billion yuan [1] - Additionally, the company has 10 new projects that have been bid but not yet signed, amounting to 764 million yuan [1] - As of the end of the reporting period, the company has a total of 356 signed but uncompleted projects, with a cumulative value of 27.027 billion yuan [1] Group 2 - The contract price for the Urumqi East Entrance Elevated Road EPC project is 4.043 billion yuan, and the project has been completed 100% [1] - The Changji Prefecture important provincial road concession project has a contract price of 2.145 billion yuan, with 9.92% of the project completed [1]

A股减速器板块震荡走强，八一钢铁、国统股份、天山股份、西部建设涨停，青松建化、雪峰科技、新 疆交建、特变电工等纷纷上涨。 ...

Investment Rating - The industry investment rating is "Overweight" [2][22]. Core Viewpoints - The economy showed stable growth in the first half of 2025, with GDP increasing by 5.3% year-on-year. However, fixed asset investment growth weakened, with a cumulative year-on-year increase of 2.8%, down 0.9 percentage points from January to May [3][4]. - Infrastructure investment growth also weakened, with total infrastructure investment (including all categories) increasing by 8.9% year-on-year, a decrease of 1.5 percentage points compared to January to May. Notably, investment in transportation, warehousing, and postal services rose by 5.6% year-on-year, while investment in water conservancy, environment, and public facilities management increased by 3.5% [4][7]. - Real estate investment remained low, with a year-on-year decrease of 11.2% in the first half of 2025. The decline in construction starts and completions narrowed, with starts down 20.0% and completions down 14.8% year-on-year [7][8]. Summary by Sections Economic Overview - The first half of 2025 saw a GDP growth of 5.3%, with quarterly growth rates of 5.4% in Q1 and 5.2% in Q2. Fixed asset investment growth was at 2.8%, with manufacturing investment increasing by 7.5% [3][4]. Infrastructure Investment - Infrastructure investment (all categories) grew by 8.9% year-on-year, while investment excluding electricity increased by 4.6%. Transportation and postal services saw a 5.6% increase, while water and environmental management investment rose by 3.5% [4][5]. Real Estate Investment - Real estate investment decreased by 11.2% year-on-year, with construction starts down 20.0% and completions down 14.8%. The pace of investment recovery is expected to be slower than in previous cycles, highlighting the need for more supportive policies [7][8]. Investment Recommendations - The report suggests that the overall industry is currently weak, but regional investments may gain momentum due to national strategic initiatives. Recommended companies include state-owned enterprises like China Chemical, China Energy Construction, and China Railway Construction, as well as private firms like Zhi Te New Materials and Honglu Steel Structure [15].

I. [Current Period Performance Forecast](index=1&type=section&id=Current%20Period%20Performance%20Forecast) This section details the company's projected financial performance for the first half of 2025, including significant increases in net profit and non-recurring gains [Performance Forecast Period](index=1&type=section&id=Performance%20Forecast%20Period) The company's performance forecast covers the period from January 1, 2025, to June 30, 2025 - The performance forecast period is from **January 1, 2025, to June 30, 2025**[3](index=3&type=chunk) [Performance Forecast Details](index=1&type=section&id=Performance%20Forecast%20Details) The company anticipates a substantial year-on-year increase in net profit attributable to shareholders and net profit after deducting non-recurring items for the first half of 2025 Key Financial Indicators for H1 2025 Performance Forecast | Indicator | Estimated for Current Period (million RMB) | Prior Period (million RMB) | Year-on-Year Growth Rate | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 205 – 305 | 71.6855 | 185.97% - 325.47% | | Net Profit After Deducting Non-Recurring Items | 97 – 145 | 71.8905 | 34.93% - 101.70% | | Basic Earnings Per Share (RMB/share) | 0.315 – 0.465 | 0.11 | - | II. [Communication with Accounting Firm](index=1&type=section&id=Communication%20with%20Accounting%20Firm) This section confirms preliminary communication with the accounting firm regarding the unaudited performance forecast, indicating no disagreements [Accounting Firm Communication Status](index=1&type=section&id=Accounting%20Firm%20Communication%20Status) The performance forecast has not been audited by a certified public accountant, but preliminary communication indicates no discrepancies - The current period performance forecast has **not been audited** by a certified public accountant[4](index=4&type=chunk) - There are **no disagreements** between the company and the accounting firm regarding the performance forecast[4](index=4&type=chunk) III. [Explanation of Performance Changes](index=1&type=section&id=Explanation%20of%20Performance%20Changes) This section explains the primary drivers behind the significant increase in net profit, mainly attributed to a one-time equity transfer [Main Reasons for Performance Growth](index=1&type=section&id=Main%20Reasons%20for%20Performance%20Growth) The substantial increase in net profit is primarily due to an investment gain from the equity transfer of Xinjiang Jiangnao Railway Co., Ltd., classified as non-recurring income - The year-on-year increase in net profit is primarily due to increased investment income from the **equity transfer of Xinjiang Jiangnao Railway Co., Ltd.** completed this year[5](index=5&type=chunk) - This equity transfer is classified as a non-recurring gain or loss, impacting current period profit by **108 million to 160 million RMB**[5](index=5&type=chunk)[6](index=6&type=chunk) IV. [Risk Warning](index=2&type=section&id=Risk%20Warning) This section addresses potential risks related to the accuracy of the performance forecast [Accuracy Risk of Performance Forecast](index=2&type=section&id=Accuracy%20Risk%20of%20Performance%20Forecast) The company asserts that there are no significant uncertainties affecting the accuracy of the current performance forecast - The company confirms there are **no significant uncertainties** affecting the accuracy of this performance forecast[7](index=7&type=chunk) V. [Other Relevant Information](index=2&type=section&id=Other%20Relevant%20Information) This section clarifies the preliminary nature of the forecast and advises investors on associated investment risks [Nature of Performance Forecast and Investment Risks](index=2&type=section&id=Nature%20of%20Performance%20Forecast%20and%20Investment%20Risks) This performance forecast is a preliminary estimate by the finance department, unaudited by an accounting firm, and investors are advised to exercise caution - This performance forecast represents a **preliminary estimate** by the company's finance department and has **not been audited** by an accounting firm[8](index=8&type=chunk) - The **final financial data** will be based on the company's disclosed 2025 semi-annual report[8](index=8&type=chunk) - Investors are advised to **exercise caution** in their decisions and be aware of investment risks[8](index=8&type=chunk)